Yesterday evening (Thursday 19th September), Brain Tumour Research attended the Francis Crick Institute, London for the launch of LifeArc’s research strategy for childhood cancer.
LifeArc is a British life science medical research charity.
It was established in 2000 as MRC Technology, to translate the work of UK Medical Research Council (MRC) research scientists.
The strategy will focus on developing new treatments, improving clinical trials, and supporting clinicians to make better decisions.
One initiative already launched is C-Further, an international consortium of researchers, clinicians, scientists in drug discovery and development, partners and impact investors with a shared commitment to creating new cancer therapeutics for children and young people, founded jointly by LifeArc and Cancer Research Horizons.
£28 million has already been set aside to support this endeavour.
We look forward to learning more about other approaches that LifeArc will take to deliver on these objectives and exploring how we, and the research community, can help support it.
Published Friday 20th September 2024.